Loading clinical trials...

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

NCT02139007•University of Alabama at Birmingham

Summary

This is a pilot study evaluating the recruitment strategies for sites and patients, data collection instruments, follow-up procedures, administrative processes, and the proposed management strategy for the future large scale national trial.

Eligibility

Age

65 - 100 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1.Females 65+
•2.3+ years of alendronate (Fosamax/Binosto) use
•3\. Valid social security number

Exclusion Criteria

•1. History of any other metabolic bone condition, such as Paget Disease of Bone
•2. Currently receiving treatment for ongoing cancer, excluding non-melanoma skin cancer.
•3. Has significant underlying illness that would be expected to prevent completion of the study (e.g., life-threatening disease likely to limit survival to less than 3 years)?
•4. HIV positive
•5. Involved in a conflicting (investigational drug) clinical trial

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Key Dates

Start Date

June 1, 2014

Primary Completion Date

June 1, 2016

Completion Date

July 1, 2016

Last Updated

May 12, 2017

Enrollment

ACTUAL participants

Conditions

Osteoporosis

Interventions

Alendronate

DRUG

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

NCT06731608

OsteoporosisLower Limb Fracture

View study

RECRUITINGPHASE4

Step-down Therapy After Long-term Osteoporosis Treatment

NCT07281586

Osteoporosis

View study

RECRUITING

Smart Wearable Device (gaitQ): Walk Better Project

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 12, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

Inclusion Criteria

Exclusion Criteria

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

Step-down Therapy After Long-term Osteoporosis Treatment

Smart Wearable Device (gaitQ): Walk Better Project

Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device